A stem cell trial on a dozen Type 1 diabetes patients suffering from a severe form of the disease has provided at least a temporary cure for 10 participants. The remaining two also dramatically reduced the amount of insulin they require daily. The treatment, with an infusion called zimislecel, was created by Vertex Pharmaceuticals and has been the life’s work …
Read More »New diabetes trial provides at least temporary cure for small group of severe Type 1 patients
